If you made any changes in Pure, your changes will be visible here soon.

Research Output 1973 2019

Filter
Review article
Review article
15 Citations (Scopus)

Cancer immunotherapy: moving forward with peptide T cell vaccines

Kumai, T., Fan, A., Harabuchi, Y. & Celis, E., Aug 1 2017, In : Current Opinion in Immunology. 47, p. 57-63 7 p.

Research output: Contribution to journalReview article

Peptide T
Immunotherapy
Vaccines
T-Lymphocytes
Neoplasms
50 Citations (Scopus)

Challenges in the development of effective peptide vaccines for cancer

Buteau, C., Markovic, S. N. & Celis, E., Jan 1 2002, In : Mayo Clinic Proceedings. 77, 4, p. 339-349 11 p., 61787.

Research output: Contribution to journalReview article

Subunit Vaccines
Vaccines
Immune System
Neoplasms
Safety
20 Citations (Scopus)

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut, R. W., Sette, A., Celis, E., Wentworth, P., Kubo, R. T., Alexander, J., Ishioka, G., Vitiello, A. & Grey, H. M., 1995, In : Pharmaceutical biotechnology. 6, p. 847-874 28 p.

Research output: Contribution to journalReview article

Drug Design
Cytotoxic T-Lymphocytes
Cellular Immunity
Immunotherapy
Communicable Diseases
14 Citations (Scopus)

Designing therapeutic cancer vaccines by mimicking viral infections

Sultan, H., Fesenkova, V., Addis, D., Fan, A. E., Kumai, T., Wu, J., Salazar, A. M. & Celis, E., Feb 1 2017, In : Cancer Immunology, Immunotherapy. 66, 2, p. 203-213 11 p.

Research output: Contribution to journalReview article

Cancer Vaccines
Virus Diseases
Epitopes
Peptides
Neoplasm Antigens
41 Citations (Scopus)

Immunogenicity of protein therapeutics and the interplay between tolerance and antibody responses

Barbosa, M. D. F. S. & Celis, E., Aug 1 2007, In : Drug Discovery Today. 12, 15-16, p. 674-681 8 p.

Research output: Contribution to journalReview article

Dendritic Cells
Antibody Formation
Epitopes
Immunoglobulin Class Switching
T-Lymphocytes
243 Citations (Scopus)

Multiple roles for CD4+ T cells in anti-tumor immune responses

Kennedy, R. & Celis, E., Apr 1 2008, In : Immunological Reviews. 222, 1, p. 129-144 16 p.

Research output: Contribution to journalReview article

T-Lymphocytes
Neoplasms
Lymphocytes
Th1 Cells
Autoantigens
40 Citations (Scopus)

Peptide epitope identification for tumor-reactive CD4 T cells

Kobayashi, H. & Celis, E., Apr 1 2008, In : Current Opinion in Immunology. 20, 2, p. 221-227 7 p.

Research output: Contribution to journalReview article

Epitopes
T-Lymphocytes
Peptides
Neoplasms
Immunotherapy
28 Citations (Scopus)

Peptide vaccines in cancer — old concept revisited

Kumai, T., Kobayashi, H., Harabuchi, Y. & Celis, E., Apr 1 2017, In : Current Opinion in Immunology. 45, p. 1-7 7 p.

Research output: Contribution to journalReview article

Subunit Vaccines
T-Lymphocytes
Neoplasms
Synthetic Vaccines
Vaccines
18 Citations (Scopus)

Synthetic antigenic peptides as a new strategy for immunotherapy of cancer.

Appella, E., Loftus, D. J., Sakaguchi, K., Sette, A. & Celis, E., Jan 1 1995, In : Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity. 1, 3, p. 177-184 8 p.

Research output: Contribution to journalReview article

Immunotherapy
Major Histocompatibility Complex
Peptides
Neoplasms
CD4 Antigens
21 Citations (Scopus)

T-cell epitope peptide vaccines

Elsawa, S. F., Rodeberg, D. A. & Celis, E., Oct 1 2004, In : Expert Review of Vaccines. 3, 5, p. 563-575 13 p.

Research output: Contribution to journalReview article

Subunit Vaccines
T-Lymphocyte Epitopes
T-Lymphocytes
Neoplasms
Neoplasm Antigens
42 Citations (Scopus)

Toll-like receptor ligands energize peptide vaccines through multiple paths

Celis, E., Sep 1 2007, In : Cancer Research. 67, 17, p. 7945-7947 3 p.

Research output: Contribution to journalReview article

Subunit Vaccines
Toll-Like Receptors
Ligands
Immunologic Adjuvants
Active Immunotherapy
47 Citations (Scopus)

TriVax-HPV: An improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

Barrios, K. & Celis, E., Aug 1 2012, In : Cancer Immunology, Immunotherapy. 61, 8, p. 1307-1317 11 p.

Research output: Contribution to journalReview article

Vaccination
Peptides
Neoplasms
Therapeutics
T-Lymphocytes